Search

Compugen Ltd

Cerrado

2.13 8.67

Resumen

Variación precio

24h

Actual

Mínimo

1.95

Máximo

2.17

Métricas clave

By Trading Economics

Ingresos

663K

-7M

Ventas

426K

2.6M

P/B

Media del Sector

5.184

48.735

BPA

-0.07

Margen de beneficios

-269.254

Empleados

75

EBITDA

665K

-7M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+128.43% upside

Dividendos

By Acuity

Próximas Ganancias

9 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-39M

187M

Apertura anterior

-6.54

Cierre anterior

2.13

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 oct 2026, 23:56 UTC

Correlated Moves

Texas Instruments Inc is trading higher in after-market hours, advancing after Tuesday's close, while STMicroelectronics NV also gains following three consecutive sessions of increases.

20 oct 2026, 23:56 UTC

Brown & Brown Inc shares are modestly lower in after-market trading, retracing from a peak shortly after the market closed.

20 oct 2026, 23:56 UTC

Bath & Body Works Inc shares declined notably in after-market trading.

20 oct 2026, 23:56 UTC

MetLife Inc shares are trading modestly higher in after-market hours, positioned significantly above its 20-day moving average and near the upper end of its one-month range.

20 oct 2026, 23:56 UTC

Steel Dynamics Inc's shares traded roughly flat in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

20 oct 2026, 23:53 UTC

Mexico's Upcoming Balance of Trade Data on October 27 Sparks Caution Amidst Mixed Sentiment and Political Optimism.

20 oct 2026, 23:52 UTC

News

Northern Trust appoints Rima Qureshi, former Verizon chief strategy officer, to its board of directors, effective immediately, enhancing its technology expertise.

20 oct 2026, 23:51 UTC

RenaissanceRe Holdings Ltd is advancing in after-market trading, reaching its highest cumulative return since Tuesday's close and significantly above its 20-day moving average.

20 oct 2026, 23:51 UTC

FedEx Corp shares are declining in after-market trading.

20 oct 2026, 23:51 UTC

Donnelley Financial Solutions Inc advanced in after-market trading, remaining significantly above its 20-day moving average since Tuesday's close.

20 oct 2026, 23:51 UTC

Axsome Therapeutics Inc shares advanced sharply in after-market trading, rising from a low shortly after the market closed to a session high.

20 oct 2026, 23:51 UTC

Automatic Data Processing Inc is declining in after-market trading, retracing from initial losses and remaining above its 20-day moving average despite the drop.

20 oct 2026, 23:51 UTC

Correlated Moves

Kratos Defense and Security Solutions Inc shares traded higher during after-market hours following the announcement of Rocket Lab Corp's upcoming financial results for Q3 2026.

20 oct 2026, 23:51 UTC

Mattel Inc is advancing in after-market trading, reaching its highest point of the day and remaining above its 20-day moving average.

20 oct 2026, 23:51 UTC

DraftKings Inc shares are trading lower in after-market hours, retracing from an earlier high and nearing their lowest level of the day.

20 oct 2026, 23:51 UTC

Tilray Brands Inc. is advancing in after-market hours, moving higher alongside the broader market, despite recent challenges in the housing sector.

20 oct 2026, 23:51 UTC

Correlated Moves

Wolfspeed Inc. is trading higher in after-market hours, moving alongside the semiconductor sector and the YieldMax Semiconductor Portfolio Option Income ETF (CHPY).

20 oct 2026, 23:51 UTC

Tootsie Roll Industries Inc. is trading modestly higher in after-market hours, reaching its highest cumulative return of the day.

20 oct 2026, 23:51 UTC

Dutch Bros Inc shares traded modestly higher during after-market hours on Tuesday, diverging from the recent trend of higher daily closes.

20 oct 2026, 23:51 UTC

Tractor Supply Co shares fell in after-market trading, declining from earlier gains and experiencing significant volatility since Tuesday's close.

20 oct 2026, 23:51 UTC

Liquidia Corp's shares are trading lower in after-market hours, following a brief rally, amid significant declines in the Pharmaceuticals sub-sector.

20 oct 2026, 23:51 UTC

Shell PLC shares are declining in after-market trading, falling sharply after a period of relative strength above its 20-day moving average.

20 oct 2026, 23:51 UTC

Monster Beverage Corp shares are trading modestly lower in after-market hours, having declined from an early high and falling below Tuesday's close.

20 oct 2026, 23:51 UTC

HCI Group Inc has advanced in after-market trading, showing a notable upward movement since Tuesday's close and peaking above its 20-day moving average.

20 oct 2026, 23:51 UTC

Correlated Moves

Marvell Technology Inc shares are advancing in after-market hours, supported by strength in the semiconductor sector and gains in the iShares Semiconductor ETF.

20 oct 2026, 23:51 UTC

Macro News

The NZD/USD pair is trading higher, supported by a weaker U.S. dollar amid easing inflation concerns and falling crude oil prices.

20 oct 2026, 23:51 UTC

In after-market trading, New York Times Co shares are lower following earlier gains.

20 oct 2026, 23:46 UTC

Papa John's International Inc shares are trading modestly higher in after-market hours, recovering from a low and showing strength after three sessions of declines.

20 oct 2026, 23:46 UTC

Ares Management Corp is trading modestly higher in after-market hours, continuing an upward trend following three consecutive daily gains.

20 oct 2026, 23:46 UTC

Correlated Moves

OneMain Holdings Inc shares advanced modestly higher in after-market trading, coinciding with Capital One Financial's strong third-quarter results that exceeded earnings estimates.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

128.43% repunte

Estimación a 12 Meses

Media 4.5 USD  128.43%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat